戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 sition (MPT), and aristolochic acid (ArA), a phospholipase A2 inhibitor.
2 exposure to fatty acid-free BSA or cytosolic phospholipase A2 inhibitors.
3 nt of DARas with antioxidants or a cytosolic phospholipase A2 inhibitor also restores the wild-type p
4                       Incubation of MCs with phospholipase A2 inhibitors also blocked Akt/PKB activat
5       We also demonstrate that the cytosolic phospholipase A2 inhibitor arachidonyl trifluoro methyl
6 the effects of a putative specific cytosolic phospholipase A2 inhibitor, arachidonyl trifluoromethyl
7  cyclosporin A (CyA) in combination with the phospholipase A2 inhibitor aristolochic acid (ArA).
8            In contrast, a specific cytosolic phospholipase A2 inhibitor blocked the oxidant productio
9 ng II activated p21ras and that mepacrine, a phospholipase A2 inhibitor, blocked this effect.
10                                              Phospholipase A2 inhibitors (BPB, ONO-RS-082, quinacrine
11 iac myocytes with urocortin, or the specific phospholipase A2 inhibitor bromoenol lactone, reduces th
12 ith 5 microm 12-epi-scalaradial, a secretory phospholipase A2 inhibitor, caused similar changes in ce
13             Cells treated with the cytosolic phospholipase A2 inhibitor, cPLA2alpha, had no effect on
14 e ER relocation of endogenous GC proteins by phospholipase A2 inhibitors demonstrate that Golgi-ER cy
15  phospholipase A2 and lipoprotein-associated phospholipase A2 inhibitors hold promise for the reducti
16                                Quinacrine, a phospholipase A2 inhibitor, inhibited ET-1-induced cAMP
17                           This suggests that phospholipase A2 inhibitors may represent a novel mode o
18          Extracellular administration of the phospholipase A2 inhibitors mepacrine and 4-bromophenacy
19                     Co-administration of the phospholipase A2 inhibitor quinacrine virtually eliminat
20                                              Phospholipase A2 inhibitors triggered similar responses,
21 des the rationale for the development of the phospholipase A2 inhibitors varespladib methyl and darap
22 logy of RoBo-1 is to the snake serum-derived phospholipase A2 inhibitors, which uniquely contain two

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。